Core Viewpoint - The company, Anhui Huaren Health Pharmaceutical Co., Ltd., is actively expanding its presence in the health sector for the elderly, focusing on chronic disease management and product development tailored to the needs of older adults [2][3]. Group 1: Company Overview - Anhui Huaren Health Pharmaceutical Co., Ltd. was established on June 29, 2001, and is located in Hefei, Anhui Province. The company was listed on March 1, 2023, and primarily engages in pharmaceutical agency, retail, and terminal procurement [7]. - The main business revenue composition includes 97.60% from traditional Chinese and Western medicine, with the remaining 2.40% from other sources [7]. - The company is categorized under the pharmaceutical and biological industry, specifically in the pharmaceutical commercial sector, with concepts including small-cap, retail pharmacies, and pharmaceutical e-commerce [7]. Group 2: Financial Performance - As of September 30, 2025, the company reported a revenue of 3.892 billion yuan, representing a year-on-year growth of 19.06%. The net profit attributable to shareholders was 157 million yuan, showing a 45.21% increase compared to the previous year [8]. - The company has distributed a total of 80.02 million yuan in dividends since its A-share listing [8]. - The number of shareholders decreased by 22.86% to 20,100, while the average circulating shares per person increased by 29.64% to 7,422 shares [8]. Group 3: Market Activity - On November 6, the company's stock price fell by 1.49%, with a trading volume of 193 million yuan and a turnover rate of 9.43%, resulting in a total market capitalization of 5.540 billion yuan [1]. - The main capital inflow for the day was negative at 8.1183 million yuan, indicating a lack of clear trends in major capital movements [4][5]. - The average trading cost of the stock is 13.62 yuan, with the stock price approaching a resistance level of 14.00 yuan, suggesting potential for upward movement if this level is surpassed [6].
华人健康跌1.49%，成交额1.93亿元，近3日主力净流入2241.70万